Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Kyowa Kirin to Carry Out Novel Target Discovery Using US Firm’s AI-Platform
December 11, 2020
- Kobayashi Kako Recalls Trigger Shipment Control for Kaken's Itraconazole Product
December 11, 2020
- (Update) Criminal Charges Sought against 3 Wholesalers over Bid-Rigging, Mediceo Excluded
December 10, 2020
- Biogen Files Japan NDA for Aducanumab
December 10, 2020
- Takeda Aiming for Sales of 5 Trillion Yen by FY2030, Sees It Realistic Target with Strong Pipeline
December 10, 2020
- Pfizer Files Abrocitinib in Japan; 3rd Oral JAK Inhibitor for Atopic Dermatitis
December 10, 2020
- With Contaminated Itraconazole, Patients Might Have Taken Sleep Inducer at 10-20 Times Regular Dosage
December 9, 2020
- Criminal Charges Sought against 3 Wholesalers over Bid-Rigging, Mediceo Excluded
December 9, 2020
- Takeda’s HAE Med Takhzyro Approved in China
December 9, 2020
- M3, NBI Pair Up to Develop AI-Powered Diagnostic Support for Lung Diseases
December 9, 2020
- Sanofi’s Kawagoe Site Aims to Join World’s Top 10% Productivity List by 2022-End
December 8, 2020
- China’s Bidding System at National Hospitals Hurting Japan Firms' Off-Patent Drug Sales; Eisai, Kaken, Santen Suffer Drops
December 8, 2020
- Hisamitsu’s NSAIDs Patch Hits Primary Goals in 2 PIII Studies
December 8, 2020
- Japan Ethical Drug Sales Down 3.3% in October: Crecon
December 8, 2020
- Maribavir Hits Primary Goal for Post-Transplant CMV Infection: Takeda
December 8, 2020
- Kobayashi Kako Launches Another Recall for Itraconazole, Class II This Time
December 8, 2020
- Astellas in Oncolytic Virus Deal with KaliVir
December 8, 2020
- Astellas, Viatris Wind Up Japan Celecox Copromotion at December-End
December 8, 2020
- Kyle Tattle to Take Reins of MSD Japan from January
December 8, 2020
- Teijin Pharma’s Spasticity Med Xeomin Now Available
December 7, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…